127 related articles for article (PubMed ID: 15309202)
21. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O
Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309
[TBL] [Abstract][Full Text] [Related]
22. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen.
Wilson AM; Ryan MC; Boyle AJ
Int J Cardiol; 2006 Jan; 106(3):291-7. PubMed ID: 16337036
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
24. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
[TBL] [Abstract][Full Text] [Related]
25. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036
[TBL] [Abstract][Full Text] [Related]
26. Exercise and the coronary circulation-alterations and adaptations in coronary artery disease.
Linke A; Erbs S; Hambrecht R
Prog Cardiovasc Dis; 2006; 48(4):270-84. PubMed ID: 16517248
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells.
Suh W; Kim KL; Choi JH; Lee YS; Lee JY; Kim JM; Jang HS; Shin IS; Lee JS; Byun J; Jeon ES; Kim DK
Biochem Biophys Res Commun; 2004 Aug; 321(1):65-71. PubMed ID: 15358216
[TBL] [Abstract][Full Text] [Related]
28. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient.
Fichtlscherer S; Breuer S; Zeiher AM
Circulation; 2004 Oct; 110(14):1926-32. PubMed ID: 15451794
[TBL] [Abstract][Full Text] [Related]
30. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.
Kang DH; Park SK; Lee IK; Johnson RJ
J Am Soc Nephrol; 2005 Dec; 16(12):3553-62. PubMed ID: 16251237
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study.
Walter MF; Jacob RF; Jeffers B; Ghadanfar MM; Preston GM; Buch J; Mason RP;
J Am Coll Cardiol; 2004 Nov; 44(10):1996-2002. PubMed ID: 15542282
[TBL] [Abstract][Full Text] [Related]
32. High levels of C-reactive protein with low total cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease.
Jánoskuti L; Förhécz Z; Hosszúfalusi N; Kleiber M; Walentin S; Bálint O; Duba J; Rugonfalvi-Kiss S; Romics L; Karádi I; Füst G; Prohászka Z
Eur J Clin Invest; 2005 Feb; 35(2):104-11. PubMed ID: 15667581
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary artery hypertension: caveolin-1 and eNOS interrelationship: a new perspective.
Mathew R; Huang J; Gewitz MH
Cardiol Rev; 2007; 15(3):143-9. PubMed ID: 17438380
[TBL] [Abstract][Full Text] [Related]
35. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
Yosef-Levi IM; Grad E; Danenberg HD
Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
[TBL] [Abstract][Full Text] [Related]
36. Value of CRP in coronary risk determination.
Mehta JL; Sukhija R; Romeo F; Sepulveda JL
Indian Heart J; 2007; 59(2):173-7. PubMed ID: 19122252
[TBL] [Abstract][Full Text] [Related]
37. [C-reactive protein in patients with coronary heart disease].
Rajtar R; Kolasińska-Kloch W; Kloch M
Folia Med Cracov; 2004; 45(1-2):25-32. PubMed ID: 16276823
[TBL] [Abstract][Full Text] [Related]
38. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function.
Pizzi C; Manzoli L; Mancini S; Costa GM
Eur Heart J; 2008 May; 29(9):1110-7. PubMed ID: 18400765
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.
Li L; Roumeliotis N; Sawamura T; Renier G
Circ Res; 2004 Oct; 95(9):877-83. PubMed ID: 15472120
[TBL] [Abstract][Full Text] [Related]
40. [The role of C-reactive protein and other acute phase markers in atherosclerosis].
Gusev DE; Ponomar' EG
Klin Med (Mosk); 2006; 84(5):25-30. PubMed ID: 16827274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
